drugset / Trial / NCT01403506

Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)

NCT01403506

RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to investigate the effect of (NAC) N-Acetyl Cysteine on biomarkers of Delayed Graft Function (DGF), including Neutrophil Gelatinase Associated Lipocalin (NGAL) and Intereleukin 18 (IL18).

Timeline

Start
2011-04
Primary completion
2012-04
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 600 mg Other